Interviewed live on BNN Bloomberg (Canada) on the market for GLP-1 drugs for weight loss and their impact on both the health care system and consumer goods and services — notably, food, nutrition, retail health, gyms, and other sectors.
Jane interviewed on market for GLP-1 meds for weight loss and impact on consumer goods companies with BNN Bloomberg
By Jane Sarasohn-Kahn on 24 May 2024 in
Interviewed live on BNN Bloomberg (Canada) on the market for GLP-1 drugs for weight loss and their impact on both the health care system and consumer goods and services -- notably, food, nutrition, retail health, gyms, and other sectors.
Thank you, Feedspot, for citing the Health Populi blog as one of the best in the field this year! Very grateful to be among the company of some of my own go-to's such as Everyday Health, NPR Health Shots, Health Affairs, and Kaiser Health News, among others...
As you may know, I have been splitting work- and living-time between the U.S. and the E.U., most recently living in and working from Brussels. In the month of September 2024, I'll be splitting time between London and other parts of the U.K., and Italy where I'll be working with clients on consumer health, self-care and home care focused on food-as-medicine, digital health, business and scenario planning for the future...